FDA Aims To Streamline Rules To Boost Development Of Biosimilar Drugs
According to the Food and Drug Administration, biologic medicines make up about 5% of prescriptions, yet they account for 51% of drug spending. Other FDA news is on a probe into rare-disease drug denials, flavored e-cigarettes, and more.